Rhumbline Advisers Dr Reddys Laboratories LTD Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Rhumbline Advisers holds 77,068 shares of RDY stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
77,068
Previous 75,643
1.88%
Holding current value
$1.08 Million
Previous $5.76 Million
6.25%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding RDY
# of Institutions
250Shares Held
33.5MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.11.4MShares$160 Million0.35% of portfolio
-
Morgan Stanley New York, NY2.24MShares$31.4 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$28 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$27.3 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$25.2 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.33B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...